metformin has been researched along with Carcinoma, Large Cell in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Carcinoma, Large Cell: A tumor of undifferentiated (anaplastic) cells of large size. It is usually bronchogenic. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metformin use was associated with improved survival, especially LCSS in patients with regional stage SCC." | 1.62 | Metformin use and lung cancer survival: a population-based study in Norway. ( Botteri, E; Brancher, S; Damhuis, RAM; Johannesen, TB; Strand, TE; Støer, NC; Weiderpass, E, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brancher, S | 1 |
| Støer, NC | 1 |
| Weiderpass, E | 1 |
| Damhuis, RAM | 1 |
| Johannesen, TB | 1 |
| Botteri, E | 1 |
| Strand, TE | 1 |
1 other study available for metformin and Carcinoma, Large Cell
| Article | Year |
|---|---|
Metformin use and lung cancer survival: a population-based study in Norway.
Topics: Adenocarcinoma of Lung; Aged; Aged, 80 and over; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lu | 2021 |